Use of local antiviral therapy for glossitis caused by the herpes virus type IV: a clinical experience

Abstract

BACKGROUND: This article discusses approaches to the diagnosis and treatment of glossitis caused by the herpes virus type IV using a local antiviral component (Epstein–Barr virus, EBV). The results of the clinical and laboratory picture of the disease in dynamics before and after treatment (3 and 6 months) were studied. Clinically significant results were obtained, confirming the effectiveness of the proposed treatment method.

AIM: To develop a highly effective protocol for the treatment of EBV-related glossitis.

MATERIALS AND METHODS: Fifty patients aged 27–52 years diagnosed with EBV-related glossitis were examined. All patients underwent PCR diagnostics for HSV-1, HSV-2, EBV, CMV and herpes virus type 6 in saliva and EBV DNA in blood and serological examination for EBV antigens. An infectious disease specialist and local antiviral therapy, that is, appropriate gels/liniments, were included in the treatment for glossitis. Its clinical and laboratory efficacy was investigated 3 and 6 months after treatment.

RESULTS: EBV was detected in all the examined patients, at a concentration of 14000–1200000 mg/ml. HSV-2 and CMV were often detected in the participants of this study (up to 70%) at a concentration of 720–12000 mg/ml, along with a low detection rate of HSV-1 and HSV-6 in saliva (up to 7%, respectively) at a concentration of 540–820 mg/ml. The viral load of EBV in the blood was detected in 15.2% of the patients (0.6–3.4 Ig 105 copies/ml). Analysis of the ELISA results revealed Ig class G to NA, VCA, and EBNA antigens of EBV.

CONCLUSION: The use, along with a systemic, local antiviral component, is highly effective in the treatment of glossitis caused by EBV, including when EBV coexists with other types of herpes virus.

Keywords

glossitis / herpes simplex virus / Epstein–Barr virus / dysbiosis / antiviral therapy

References

[1] Kuri A, Jacobs BM, Vickaryous N, et al. Epidemiology of Epstein–Barr virus infection and infectious mononucleosis in the United Kingdom. BMC Public Health. 2020;20(1):912. doi: 10.1186/s12889-020-09049-x

[2] Kuri A., Jacobs B.M., Vickaryous N., et al. Epidemiology of Epstein–Barr virus infection and infectious mononucleosis in the United Kingdom // BMC Public Health. 2020. Vol. 20, N 1. P. 912. doi: 10.1186/s12889-020-09049-x

[3] Heawchaiyaphum C, Iizasa H, Ekalaksananan T, et al. Epstein–Barr virus infection of oral squamous cells. Microorganisms. 2020;8(3):419. doi: 10.3390/microorganisms8030419

[4] Heawchaiyaphum C., Iizasa H., Ekalaksananan T., et al. Epstein–Barr virus infection of oral squamous cells // Microorganisms. 2020. Vol. 8, N 3. P. 419. doi: 10.3390/microorganisms8030419

[5] Belozertseva OP, Artemieva IA, Bolshedvorskaya NE. Diagnosis of diseases in patients with Epstein–Barr virus at dental appointments. In: Actual problems of pediatric stomatology. Proceedings of the VII All-Russian scientific-practical conference. Irkutsk: INCHT; 2021. P. 28–36. (In Russ). EDN: QPUOLI

[6] Белозерцева О.П., Артемьева И.А., Большедворская Н.Е. Диагностика заболеваний у пациентов на стоматологическом приеме с вирусом Эпштейна–Барр. В кн.: Актуальные проблемы стоматологии детского возраста. Материалы VII Всероссийской научно-практической конференции. Иркутск: ИНЦХТ, 2021. С. 28–36. EDN: QPUOLI

[7] Vanshika S, Preeti A, Sumaira Q, et al. Incidence OF HPV and EBV in oral cancer and their clinico-pathological correlation — a pilot study of 108 cases. J Oral Biol Craniofac Res. 2021;11(2):180–184. doi: 10.1016/j.jobcr.2021.01.007

[8] Vanshika S., Preeti A., Sumaira Q., et al. Incidence OF HPV and EBV in oral cancer and their clinico-pathological correlation — a pilot study of 108 cases // J Oral Biol Craniofac Res. 2021. Vol. 11, N 2. P. 180–184. doi: 10.1016/j.jobcr.2021.01.007

[9] AbuSalah MAH, Gan SH, Al-Hatamleh MAI, et al. Recent advances in diagnostic approaches for Epstein–Barr virus. Pathogens. 2020;9(3):226. doi: 10.3390/pathogens9030226

[10] AbuSalah M.A.H., Gan S.H., Al-Hatamleh M.A.I., et al. Recent advances in diagnostic approaches for Epstein–Barr virus // Pathogens. 2020. Vol. 9, N 3. P. 226. doi: 10.3390/pathogens9030226

[11] Kakabadze M, Paresishvili T, Karalashvili L, et al. Oral microbiota and oral cancer: review. Oncol Rev. 2020;14(2):476. doi: 10.4081/oncol.2020.476

[12] Kakabadze M., Paresishvili T., Karalashvili L., et al. Oral microbiota and oral cancer: review // Oncol Rev. 2020. Vol. 14, N 2. P. 476. doi: 10.4081/oncol.2020.476

[13] Sami A, Elimairi I, Stanton C, et al. The role of the microbiome in oral squamous cell carcinoma with insight into the microbiome–treatment axis. Int J Mol Sci. 2020;21(21):8061. doi: 10.3390/ijms21218061

[14] Sami A., Elimairi I., Stanton C., et al. The role of the microbiome in oral squamous cell carcinoma with insight into the microbiome–treatment axis // Int J Mol Sci. 2020. Vol. 21, N 21. P. 8061. doi: 10.3390/ijms21218061

[15] Mardanly SG, Arseneva VA, Mardanly SS, Rotanov SV. Prevalence of herpes viruses among contingents of different ages. Journal of Microbiology Epidemiology Immunobiology. 2019;(2):50–55. EDN: QJKJJG doi: 10.36233/0372-9311-2019-2-50-55

[16] Марданлы С.Г., Арсеньева В.А., Марданлы С.С., Ротанов С.В. Распространенность вирусов герпеса среди контингентов различного возраста // Журнал микробиологии, эпидемиологии и иммунобиологии. 2019. № 2. С. 50–55. EDN: QJKJJG doi: 10.36233/0372-9311-2019-2-50-55

[17] Serazetdinova AR, Trunin DA, Kirillova VP. Dysbiosis of oral mucosa in diseases of internal organs and ways of its correction. In: Postgraduate Readings — 2017. Proceedings of the scientific and practical conference with international participation “Scientific achievements of young scientists of the XXI century in the framework of priority directions of the strategy of scientific and technological development of the country”. Samara: Ofort LLC; 2017. P. 205–206. (In Russ). EDN: ZXCFZJ

[18] Серазетдинова А.Р., Трунин Д.А., Кириллова В.П. Дисбиоз слизистой оболочки полости рта при заболеваниях внутренних органов и пути его коррекции. В кн.: Аспирантские чтения — 2017. Материалы научно-практической конференции с международным участием «Научные достижения молодых ученых XXI века в рамках приоритетных направлений стратегии научно-технологического развития страны». Самара: ООО «Офорт», 2017. С. 205–206. EDN: ZXCFZJ

[19] Serazetdinova AR. Methods for correcting xerostomia in patients with glossitis caused by the Epstein–Barr virus. In: Postgraduate readings — 2018. Proceedings of the All-Russian scientific and practical conference with international participation. Samara: Ofort LLC; 2018. P. 154–155. EDN: DCJTCF

[20] Серазетдинова А.Р. Способы коррекции ксеростомии у больных глосситом, обусловленным вирусом Эпштейна–Барр. В кн.: Аспирантские чтения — 2018: Материалы всероссийской научно-практической конференции с международным участием. Самара: ООО «Офорт», 2018. С. 154–155. EDN: DCJTCF

[21] Azarova OA, Sevastenkova MS. Microbiome of the oral cavity: connection with systemic diseases. Applied and IT Research in Medicine. 2022;25(3):68–73. EDN: DBZSIB

[22] Азарова О.А., Севастенкова М.С. Микробиом ротовой полости: cвязь с системными заболеваниями // Прикладные информационные аспекты медицины. 2022. Т. 25, № 3. С. 68–73. EDN: DBZSIB

[23] Peng X, Cheng L, You Y, et al. Oral microbiota in human systematic diseases. Int J Oral Sci. 2022;14(1):14. doi: 10.1038/s41368-022-00163-7

[24] Peng X., Cheng L., You Y., et al. Oral microbiota in human systematic diseases // Int J Oral Sci. 2022. Vol. 14, N 1. P. 14. doi: 10.1038/s41368-022-00163-7

[25] Sun J, Tang Q, Yu S, et al. Role of the oral microbiota in cancer evolution and progression. Cancer Med. 2020;9(17):6306–6321. doi: 10.1002/cam4.3206

[26] Sun J., Tang Q., Yu S., et al. Role of the oral microbiota in cancer evolution and progression // Cancer Med. 2020. Vol. 9, N 17. P. 6306–6321. doi: 10.1002/cam4.3206

[27] Read E, Curtis MA, Neves JF. The role of oral bacteria in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2021;18(10):731–742. doi: 10.1038/s41575-021-00488-4

[28] Read E., Curtis M.A., Neves J.F. The role of oral bacteria in inflammatory bowel disease // Nat Rev Gastroenterol Hepatol. 2021. Vol. 18, N 10. P. 731–742. doi: 10.1038/s41575-021-00488-4

[29] Kudin AP. This “harmless” Epstein-Barr virus infection. Part 1. Acute EBV infection: epidemiology, clinical picture, diagnosis, treatment. Meditsinskie novosti. 2006;1(7):25–31. (In Russ).

[30] Кудин А.П. Эта «безобидная» вирус Эпштейна–Барр инфекция. Часть 1. Острая ВЭБ-инфекция: эпидемиология, клиника, диагностика, лечение // Медицинские новости. 2006. Т. 1, № 7. С. 25–31.

[31] Dzhanibekova TA, Kerdyashova AA, Ananyeva OS. Manifestation of infectious diseases in the oral cavity of children. Innovacii. Nauka. Obrazovanie. 2021;(34):3087–3091. (In Russ). EDN: SSIIOW

[32] Джанибекова Т.А., Кердяшова А.А., Ананьева О.С. Проявление инфекционных заболеваний в полости рта у детей // Инновации. Наука. Образование. 2021. № 34. С. 3087–3091. EDN: SSIIOW

[33] Chepurova NI, Romanenko IG. Corrective effect of immunological drugs on the microbiocenosis of the oral cavity in patients with chronic apical periodontitis against the background of oral dysbiosis. Parodontologiya. 2019;24(2):173–177. EDN: XCKIDB doi: 10.33925/1683-3759-2019-24-2-173-177

[34] Чепурова Н.И., Романенко И.Г. Корригирующее влияние иммунологических препаратов на микробиоценоз полости рта у больных с хроническим апикальным периодонтитом на фоне дисбиоза полости рта // Пародонтология. 2019. Т. 24, № 2. С. 173–177. EDN: XCKIDB doi: 10.33925/1683-3759-2019-24-2-173-177

[35] Chepurova NI, Romanenko IG. Influence of dysbiotic factors on immune disorders in odontogenic foci of infection. Crimean Journal of Internal Diseases. 2017;(3):43–46. EDN: ZHZMWD

[36] Чепурова Н.И., Романенко И.Г. Влияние дисбиотических факторов на иммунные нарушения при одонтогенных очагах инфекции // Крымский терапевтический журнал. 2017. № 3. С. 43–46. EDN: ZHZMWD

[37] Shcherbina MS, Chernysheva EA. Interrelation of diseases of oral cavity organs and somatic pathology. In: Week of Youth Science — 2022. Materials of the All-Russian scientific forum with international participation. Tjumen’: Reklamno-izdatel’skij centr “Ajveks”; 2022. P. 335–336. (In Russ). EDN: KGNDCX

[38] Щербина М.С., Чернышева Е.А. Взаимосвязь заболеваний органов ротовой полости и соматической патологии. В кн.: Неделя молодежной науки — 2022. Материалы Всероссийского научного форума с международным участием. Тюмень: Рекламно-издательский центр «Айвекс», 2022. С. 335–336. EDN: KGNDCX

[39] Papruzhenka T, Terechova T, Borovaya M, Belaya T. Modern aspects of herpetic infection with manifestations in the oral cavity. Dentistry. Aesthetics. Innovations. 2021;5(2):173–200. EDN VYNQTT doi: 10.34883/PI.2021.5.2.007

[40] Попруженко Т.В., Терехова Т.Н., Боровая М.Л., Белая Т.Г. Современные аспекты герпетической инфекции с проявлениями в полости рта // Стоматология. Эстетика. Инновации. 2021. Т. 5, № 2. С. 173–200. EDN VYNQTT doi: 10.34883/PI.2021.5.2.007

[41] She Y, Nong X, Zhang M, Wang M. Epstein–Barr virus infection and oral squamous cell carcinoma risk: a meta-analysis. PLoS One. 2017;12(10):e0186860. Corrected and republished from: PLoS One. 2019;14(6):e0217659. doi: 10.1371/journal.pone.0186860

[42] She Y., Nong X., Zhang M., Wang M. Epstein–Barr virus infection and oral squamous cell carcinoma risk: a meta-analysis // PLoS One. 2017. Vol. 12, N 10. P. e0186860. Corrected and republished from: PLoS One. 2019. Vol. 14, N 6. P. e0217659. doi: 10.1371/journal.pone.0186860

RIGHTS & PERMISSIONS

Eco-Vector